vs
Side-by-side financial comparison of ESAB Corp (ESAB) and Option Care Health, Inc. (OPCH). Click either name above to swap in a different company.
Option Care Health, Inc. is the larger business by last-quarter revenue ($1.4B vs $727.8M, roughly 2.0× ESAB Corp). ESAB Corp runs the higher net margin — 7.5% vs 3.6%, a 3.9% gap on every dollar of revenue. On growth, Option Care Health, Inc. posted the faster year-over-year revenue change (12.2% vs 8.5%). Option Care Health, Inc. produced more free cash flow last quarter ($130.2M vs $70.3M). Over the past eight quarters, Option Care Health, Inc.'s revenue compounded faster (13.0% CAGR vs 2.8%).
ESAB, Elektriska Svetsnings-Aktiebolaget, is an American-Swedish industrial company.
GE Healthcare Technologies, Inc. is an American health technology company based in Chicago, Illinois. The company, which stylizes its own name as GE HealthCare, operates four divisions: Medical imaging, which includes molecular imaging, computed tomography, magnetic resonance, women’s health screening and X-ray systems; Ultrasound; Patient Care Solutions, which is focused on remote patient monitoring, anesthesia and respiratory care, diagnostic cardiology, and infant care; and Pharmaceutical ...
ESAB vs OPCH — Head-to-Head
Income Statement — Q3 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $727.8M | $1.4B |
| Net Profit | $54.8M | $51.8M |
| Gross Margin | 37.0% | 19.0% |
| Operating Margin | 14.6% | 5.9% |
| Net Margin | 7.5% | 3.6% |
| Revenue YoY | 8.5% | 12.2% |
| Net Profit YoY | 2.1% | -3.8% |
| EPS (diluted) | $0.90 | $0.32 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $727.8M | — | ||
| Q3 25 | $715.6M | $1.4B | ||
| Q2 25 | $678.1M | $1.4B | ||
| Q1 25 | — | $1.3B | ||
| Q4 24 | $670.8M | $1.3B | ||
| Q3 24 | $673.3M | $1.3B | ||
| Q2 24 | $707.1M | $1.2B | ||
| Q1 24 | $689.7M | $1.1B |
| Q4 25 | $54.8M | — | ||
| Q3 25 | $66.9M | $51.8M | ||
| Q2 25 | $67.4M | $50.5M | ||
| Q1 25 | — | $46.7M | ||
| Q4 24 | $53.7M | $60.1M | ||
| Q3 24 | $68.2M | $53.9M | ||
| Q2 24 | $82.9M | $53.0M | ||
| Q1 24 | $60.0M | $44.8M |
| Q4 25 | 37.0% | — | ||
| Q3 25 | 37.2% | 19.0% | ||
| Q2 25 | 37.6% | 19.0% | ||
| Q1 25 | — | 19.7% | ||
| Q4 24 | 38.5% | 21.3% | ||
| Q3 24 | 37.7% | 20.1% | ||
| Q2 24 | 38.2% | 20.3% | ||
| Q1 24 | 37.0% | 20.8% |
| Q4 25 | 14.6% | — | ||
| Q3 25 | 15.2% | 5.9% | ||
| Q2 25 | 16.2% | 5.8% | ||
| Q1 25 | — | 5.9% | ||
| Q4 24 | 16.6% | 6.9% | ||
| Q3 24 | 15.7% | 6.7% | ||
| Q2 24 | 16.9% | 6.6% | ||
| Q1 24 | 16.0% | 6.0% |
| Q4 25 | 7.5% | — | ||
| Q3 25 | 9.3% | 3.6% | ||
| Q2 25 | 9.9% | 3.6% | ||
| Q1 25 | — | 3.5% | ||
| Q4 24 | 8.0% | 4.8% | ||
| Q3 24 | 10.1% | 4.2% | ||
| Q2 24 | 11.7% | 4.3% | ||
| Q1 24 | 8.7% | 3.9% |
| Q4 25 | $0.90 | — | ||
| Q3 25 | $1.09 | $0.32 | ||
| Q2 25 | $1.10 | $0.31 | ||
| Q1 25 | — | $0.28 | ||
| Q4 24 | $0.87 | $0.36 | ||
| Q3 24 | $1.11 | $0.31 | ||
| Q2 24 | $1.35 | $0.30 | ||
| Q1 24 | $0.98 | $0.26 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $218.2M | $309.8M |
| Total DebtLower is stronger | $1.3B | $1.2B |
| Stockholders' EquityBook value | $2.1B | $1.4B |
| Total Assets | $4.9B | $3.5B |
| Debt / EquityLower = less leverage | 0.63× | 0.86× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $218.2M | — | ||
| Q3 25 | $258.2M | $309.8M | ||
| Q2 25 | $291.3M | $198.8M | ||
| Q1 25 | — | $171.4M | ||
| Q4 24 | $249.4M | $412.6M | ||
| Q3 24 | $253.7M | $483.0M | ||
| Q2 24 | $228.5M | $376.9M | ||
| Q1 24 | $76.5M | $219.5M |
| Q4 25 | $1.3B | — | ||
| Q3 25 | $1.1B | $1.2B | ||
| Q2 25 | $1.1B | $1.1B | ||
| Q1 25 | — | $1.1B | ||
| Q4 24 | $1.1B | $1.1B | ||
| Q3 24 | $1.1B | $1.1B | ||
| Q2 24 | $1.1B | $1.1B | ||
| Q1 24 | $992.8M | $1.1B |
| Q4 25 | $2.1B | — | ||
| Q3 25 | $2.1B | $1.4B | ||
| Q2 25 | $1.9B | $1.4B | ||
| Q1 25 | — | $1.4B | ||
| Q4 24 | $1.8B | $1.4B | ||
| Q3 24 | $1.8B | $1.4B | ||
| Q2 24 | $1.7B | $1.4B | ||
| Q1 24 | $1.6B | $1.4B |
| Q4 25 | $4.9B | — | ||
| Q3 25 | $4.4B | $3.5B | ||
| Q2 25 | $4.2B | $3.4B | ||
| Q1 25 | — | $3.3B | ||
| Q4 24 | $4.0B | $3.4B | ||
| Q3 24 | $4.1B | $3.4B | ||
| Q2 24 | $4.0B | $3.3B | ||
| Q1 24 | $3.8B | $3.2B |
| Q4 25 | 0.63× | — | ||
| Q3 25 | 0.51× | 0.86× | ||
| Q2 25 | 0.55× | 0.82× | ||
| Q1 25 | — | 0.82× | ||
| Q4 24 | 0.60× | 0.79× | ||
| Q3 24 | 0.59× | 0.78× | ||
| Q2 24 | 0.63× | 0.79× | ||
| Q1 24 | 0.61× | 0.74× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $81.5M | $139.4M |
| Free Cash FlowOCF − Capex | $70.3M | $130.2M |
| FCF MarginFCF / Revenue | 9.7% | 9.1% |
| Capex IntensityCapex / Revenue | 1.5% | 0.6% |
| Cash ConversionOCF / Net Profit | 1.49× | 2.69× |
| TTM Free Cash FlowTrailing 4 quarters | $238.0M | $220.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $81.5M | — | ||
| Q3 25 | $46.6M | $139.4M | ||
| Q2 25 | $35.4M | $90.3M | ||
| Q1 25 | — | $-7.2M | ||
| Q4 24 | $126.9M | $36.1M | ||
| Q3 24 | $101.0M | $160.4M | ||
| Q2 24 | $83.0M | $195.7M | ||
| Q1 24 | $44.5M | $-68.8M |
| Q4 25 | $70.3M | — | ||
| Q3 25 | $37.4M | $130.2M | ||
| Q2 25 | $28.1M | $81.2M | ||
| Q1 25 | — | $-16.6M | ||
| Q4 24 | $102.2M | $25.8M | ||
| Q3 24 | $90.4M | $150.7M | ||
| Q2 24 | $74.0M | $185.9M | ||
| Q1 24 | $37.1M | $-74.6M |
| Q4 25 | 9.7% | — | ||
| Q3 25 | 5.2% | 9.1% | ||
| Q2 25 | 4.1% | 5.7% | ||
| Q1 25 | — | -1.2% | ||
| Q4 24 | 15.2% | 2.0% | ||
| Q3 24 | 13.4% | 11.8% | ||
| Q2 24 | 10.5% | 15.1% | ||
| Q1 24 | 5.4% | -6.5% |
| Q4 25 | 1.5% | — | ||
| Q3 25 | 1.3% | 0.6% | ||
| Q2 25 | 1.1% | 0.6% | ||
| Q1 25 | — | 0.7% | ||
| Q4 24 | 3.7% | 0.8% | ||
| Q3 24 | 1.6% | 0.8% | ||
| Q2 24 | 1.3% | 0.8% | ||
| Q1 24 | 1.1% | 0.5% |
| Q4 25 | 1.49× | — | ||
| Q3 25 | 0.70× | 2.69× | ||
| Q2 25 | 0.53× | 1.79× | ||
| Q1 25 | — | -0.15× | ||
| Q4 24 | 2.36× | 0.60× | ||
| Q3 24 | 1.48× | 2.98× | ||
| Q2 24 | 1.00× | 3.69× | ||
| Q1 24 | 0.74× | -1.54× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ESAB
| Consumable Products | $477.9M | 66% |
| Equipment Products | $249.9M | 34% |
OPCH
| Commercial Customer | $1.3B | 87% |
| Government Customer | $172.8M | 12% |
| Patient Customer | $10.1M | 1% |
| Corporate Joint Venture | $1.9M | 0% |
